ReviewOncoTargets and therapy2014

Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives.

Xinghua Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.